MET and familial pancreatic carcinoma: Previous studies have reported that targeting the c-Met pathway overcomes chemo-resistance and stem cell signaling in pancreatic cancer [73, 74] and that Met inhibition induces chemosensitivity in gastric cancer stem cells [75].